2021 Annual Meeting | C55 - Autoimmune Neurology

Date Monday 04/19/21

Time 06:00 PM - 07:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Stacey Clardy, MD, PhD, FAAN

Moderator(s) Paola Sandroni, MD, PhD, FAAN

Topic(s) Autoimmune Neurology

Learning Objectives Participants should be able to understand the autoantibody nomenclature; recognize autoimmune neurologic disorders; know the neurologic and cancer associations of the autoantibodies; know the pitfalls in antibody testing; know the appropriate oncological evaluations for paraneoplastic neurologic disorders; and know some frequently used treatment approaches for autoimmune neurologic disorders. They should be able to understand the importance of antigen location (synaptic/cell surface compared to intracellular antigen targets), and learn about the latest advances in autoimmune epilepsy.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Introductory

Program Tracks Neurohospitalist, Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
06:00 PM - 06:25 PM EDT	Speaker	History of Autoimmune Neurology, Introduction to Autoantibodies, and Tips & Tricks Stacey Clardy, MD, PhD, FAAN
06:25 PM - 06:50 PM EDT	Speaker	Treatment Approach, Cases and The Future of Autoimmune Neurology Alfonso S. Lopez, MD
06:50 PM - 07:00 PM EDT	Q&A	Live Q&A Stacey Clardy, MD, PhD, FAAN, Alfonso S. Lopez, MD

Faculty Disclosures
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Alfonso S. Lopez, MD	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.